title: Salmeterol/fluticasone combination instead of indacaterol or vice-versa?
authors.affiliation: Pulmonary Unit, University of Verona, Verona, Italy.
authors.forename: Andrea
authors.initials: A
authors.lastname: Rossi
authors.affiliation: University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
authors.forename: Thys
authors.initials: T
authors.lastname: van der Molen
authors.affiliation: Fundación CIDEA and Hospital Maria Ferrer, Buenos Aires, Argentina.
authors.forename: Ricardo
authors.initials: R
authors.lastname: Del Olmo
authors.affiliation: Fundacion Enfisema, Buenos Aires, Argentina.
authors.forename: Luis
authors.initials: L
authors.lastname: Wehbe
mesh_terms: D000420:Albuterol / Q000031:analogs & derivatives*; D000730:Androstadienes / Q000627:therapeutic use*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007189:Indans / Q000627:therapeutic use*; D008297:Male; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D015363:Quinolones / Q000627:therapeutic use*
chemical_list: D000730:Androstadienes; D001993:Bronchodilator Agents; D005938:Glucocorticoids; D007189:Indans; D015363:Quinolones; D000420:Albuterol